SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
Clinical trial NCT06394492 · RECRUITING
Trial details
- NCT number
- NCT06394492
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-10
- Primary completion
- 2026-05-31
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.